Home

Third Rock Ventures IV reported a 13.9% stake in Maze Therapeutics MAZE · 6,073,958 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
13.9%
Last report
First report
Shares held
6,073,958 sh
Class
Common Stock, $0.001 par value per share
Event date
25/01/31
Filed
25/05/09

First 5%+ report · 13.9% stake

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/01~25/03/02

Third Rock Ventures IV's other 5% stake reports

  • Third Rock Ventures IV

    5% stakeMaze Therapeutics

    9.3% stake

    Filed 02/13

  • Third Rock Ventures IV

    5% stakeTango Therapeutics

    4.74% stake

    Filed 02/10

  • Third Rock Ventures IV

    5% stakeTango Therapeutics

    5.85% stake

    Filed 25/11/21

  • Third Rock Ventures IV

    5% stakeTango Therapeutics

    6.97% stake

    Filed 25/11/14